{"description":"As prespecified in the study protocol, All-Cause Mortality, Serious, and Other (Not Including Serious) Adverse Events data were not collected during the screening phase.","eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":0,"description":"Participants with Relapsed/Refractory Multiple Myeloma (RRMM) were screened to be randomized in sub-studies of this master protocol.","id":"EG000","otherNumAffected":0,"otherNumAtRisk":0,"seriousNumAffected":0,"seriousNumAtRisk":0,"title":"All Screened Participants"}],"frequencyThreshold":"0","timeFrame":"Adverse events were not monitored/assessed during the screening phase (Day -30 to Day 0)."}